InCube Labs, L.L.C. 13D and 13G filings for Rani Therapeutics Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-27 9:49 pm Purchase | 2025-10-23 | 13D | Rani Therapeutics Holdings, Inc. RANI | InCube Labs, L.L.C. | 27,093,552 22.100% | 4,682,428 (+20.89%) | Filing |
| 2021-08-23 4:35 pm Purchase | 2021-08-03 | 13D | Rani Therapeutics Holdings, Inc. RANI | InCube Labs, L.L.C. | 22,411,124 44.300% | 22,411,124 (New Position) | Filing |